Main Menu
Main Menu
Stay updated with news and stories of strength and hope. Learn how biomarker testing is unlocking personalized treatment options and how clinical trials are offering new paths forward.
New Brain Tumor Clinical Trials: April – October 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting since our last report for patients with a primary brain tumor. Follow the hyperlink for […] November 7, 2024
Q&A with a Pathologist (Part Two): Keith Ligon, MD, PhD The team at the National Brain Tumor Society interviewed Keith Ligon, MD, PhD, in part one of our series to help explain pathology and biomarker testing as part of NBTS’s MyTumorID campaign. NBTS launched the MyTumorID campaign this year to educate and empower patients and care partners to make informed decisions about biomarker testing and clinical […] October 7, 2024
Q&A with a Pathologist (Part One): Keith Ligon, MD, PhD The most recent WHO Classification of Tumours emphasizes the importance of biomarker testing in the diagnosis of brain tumors, yet nearly 70% of patients with brain tumors reported not understanding what biomarker testing is in a recent survey. National Brain Tumor Society launched the MyTumorID campaign this year to educate and empower patients and care […] August 27, 2024
Notes of Courage: Kai’s Childhood Cancer Story Eleven-year-old Kai C. sits down at his piano and masterfully plays his own composed song. The elementary student with an ear for music amazes his mother, Kari, as he improvises and creates pieces. With how effortlessly he moves over the keys, it might be hard to believe that Kai has experienced two recurrences, seven surgeries, […] August 26, 2024
Demystifying Clinical Trials: A Mythbusting Guide for Patients with Brain Tumors and Care Partners In 1774, a British Royal Navy surgeon named James Lind began what is now referred to as the first randomized clinical trial when he divided 12 scurvy-stricken sailors into six groups and administered various treatments. Through meticulous observation and analysis, Lind discovered that the sailors who received citrus fruits experienced significant improvements in their symptoms, […] May 20, 2024
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!